Glenn Tate - Net Worth and Insider Trading
Glenn Tate Net Worth
The estimated net worth of Glenn Tate is at least $106,167 dollars as of 2024-09-23. Glenn Tate is the Director or Senior Officer of Insider or Subsidiar of Medexus Pharmaceuticals Inc and owns about 41,634 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $106,167. Details can be seen in Glenn Tate's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenn Tate has not made any transactions after 2021-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Glenn Tate
Glenn Tate Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenn Tate owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .
Click here to see the complete history of Glenn Tate’s form 4 insider trades.
Insider Ownership Summary of Glenn Tate
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2021-08-18 | Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6) |
Glenn Tate Latest Holdings Summary
Glenn Tate currently owns a total of 1 stock. Glenn Tate owns 41,634 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of August 18, 2021, with a value of $106,167.
Latest Holdings of Glenn Tate
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2021-08-18 | 41,634 | 2.55 | 106,167 |
Holding Weightings of Glenn Tate
Glenn Tate Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenn Tate has made a total of 9 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 2,000 shares on August 18, 2021, which cost Glenn Tate around $5,784.
Insider Trading History of Glenn Tate
- 1
Glenn Tate Trading Performance
GuruFocus tracks the stock performance after each of Glenn Tate's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn Tate is 2.24%. GuruFocus also compares Glenn Tate's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn Tate within 3 months outperforms 5 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Glenn Tate's insider trading performs compared to the benchmark.
Performance of Glenn Tate
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.1 | | | | | |
| Relative Return to S&P 500(%) | 14.11 | | | | | |
Glenn Tate Ownership Network
Glenn Tate Owned Company Details
What does Medexus Pharmaceuticals Inc do?
Who are the key executives at Medexus Pharmaceuticals Inc?
Glenn Tate is the Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6) of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Brendon Buschman , Director & Senior Officer Kenneth d'Entremont , and Senior Officer Marcel Pascal Konrad .
Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary
Over the past 18 months, Glenn Tate made no insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP). Other recent insider transactions involving Medexus Pharmaceuticals Inc (TSX:MDP) include a net purchase of 20,000 shares made by Brendon Buschman , a net purchase of 7,000 shares made by Mike Mueller , and a net purchase of 18,800 shares made by Kenneth d'Entremont .
In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 147,900 shares were bought by its insiders, resulting in a net purchase of 147,900 shares.
Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medexus Pharmaceuticals Inc Insider Transactions
Glenn Tate Mailing Address
Above is the net worth, insider trading, and ownership report for Glenn Tate. Currently GuruFocus does not have mailing address information for Glenn Tate.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
